Eurocor. Interventional Cardiology.

Eurocor Headquarters Germany.
Dedicated to your heart.
Coronary stent technologies and special cardiovascular and endovascular devices made in Europe for the world.


IROS 2017 - Interventionell Radiologisches Olbert Symposium, Berlin, Germany, January 12 - 14, 2017

  • bcc Berlin Congress Center (Alexanderstraße 11, 10178 Berlin)

Poster Safari, January 13th, 13:15 – 14:00, Poster Terminals
Poster: 1802.3
The randomized Freeway Stent Study completed the 6 months follow up and favors the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segment to lower restenosis rate

We are looking forward to meeting you in Berlin, Germany.

For further information please follow http://www.irosonline.org/


The Leipzig Interventional Course (LINC), Leipzig, Germany, January 24 - 27, 2017

  • Trade Fair Leipzig, Hall 2 (Messe-Allee 1, 04356 Leipzig, Germany)

Scientific Program
ROOM 6 – SPEAKERS' CORNER Tuesday, January 24, 2017
14:25 – 14:30 Freeway stent study
“The randomized Freeway Stent Study completed the 6 months follow up and favors the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segment to lower restenosis rate“
Speaker: Stefan Müller-Hülsbeck

ROOM 7 – SPEAKERS' CORNER Wednesday, January 25, 2017
10:54 – 11:00 Freeway paclitaxel-releasing balloons reduce the risk of restenosis in hemodialysis patients with recurrent stenosis of arteriovenous fistula
Speaker: Nicola Troisi

We are looking forward to meeting you in Leipzig, Germany.

For further information please follow http://www.leipzig-interventional-course.com/


CICE 2017, Sao Paulo, Brazil, April 4th - 8th, 2017

  • Sheraton Sao Paulo WTC Hotel (Avenida das Nações Unidas 12559 - Brooklin Novo, São Paulo - SP, 04795-100 BRAZIL)
  • Exhibition Stand #31

We are looking forward to meeting you in Sao Paulo, Brazil.

For further information please follow http://www.cice.com.br/index.php


EuroPCR - The Leading Cardiovascular Course, Paris, France, May 16th - 19th, 2017

  • Palais Des Congrès de Paris (2 Place Porte Maillot, 75017 Paris, France)
  • Exhibition Stand P16, Hall Paris, Level 1

We are looking forward to meeting you in Paris, France.

For further information please follow http://europcr.com/


SOLACI - Latin American Society of Interventional Cardiology - Buenos Aires, August 2nd -4th, 2017

  • Hotel Hilton Buenos Aires Puerto Madero (AV Macacha Güemes 351, Buenos Aires, C1106BKG, Argentinien)

We are looking forward to meeting you in Buenos Aires, Argentina.

For further information please follow http://www.solacicongress.org/index.asp


CIRSE - Cardiovascular and Interventional Radiological Society of Europe
Copenhagen, Denmark, September 16th - 20th, 2017

  • Bella Center Copenhagen (Center Blvd. 5, DK - 2300 København S, Denmark)

Eurocor is proud to announce the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen.

Titel: The randomized Freeway Stent Study completed the 12-month follow-up and favored the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segments to lower restenosis rate

Session: FP 2306 - Peripheral arterial disease
Date: Monday Sept. 18, 2017
Time: 17.30 – 18.30
Place: Auditorium 11

There will also be an electronic Poster by Dr. Troisi about Freeway in AV Shunt



The Freeway Stent Study was lead-managed by Prof. Dr. Josef Tacke, Klinikum Passau, Germany. The multicenter, open, prospective randomized study investigated the prevention of restenosis in the treatment of Superficial Femoral Artery (SFA) or Popliteal artery (PI-segment) lesions in the legs. The study examined whether implantation of a Nitinol stent followed by post-dilatation with a drug-eluting balloon (DEB) FREEWAYTM is advantageous over Nitinol stenting and post-dilatation by a plain balloon (POBA). The study was conducted in 13 sites in Germany and Austria. 204 patients suffering from de novo lesions that needed to be stented were enrolled and randomized in a 1:1 ratio. Patients have been followed at 6 and 12 months.


We are looking forward to meeting you in Copenhagen, Denmark.

For further information please follow http://cirse.org/index.php?pid=1281

GulfPCR-GIM 2017, Dubai, United Arab Emirates, December 13th -14th 2017

  • Grand Hyatt Dubai, Riyadh Street, Sheikh Rashid Road, Dubai Healthcare City

Eurocor is present at Exhibition stand #13

We are looking forward to meeting you in Dubai.
For further information please follow http://www.gulfpcr.com/